# CSX Corp: financial statements, quarterly

CSX · Nasdaq · CIK 277948 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/csx.md) · [Financials](/companies/csx/financials.md) · [Filings](/companies/csx/filings.md) · [Insiders](/companies/csx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/csx/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,680 d](/filings/0000277948-26-000006.md) | [3,681](/filings/0000277948-25-000028.md) | [3,701](/filings/0000277948-25-000044.md) | [3,619](/filings/0000277948-25-000054.md) | [3,539 d](/filings/0000277948-26-000006.md) | [3,423](/filings/0000277948-26-000014.md) | [3,574](/filings/0000277948-26-000032.md) | [3,587](/filings/0000277948-26-000040.md) | [3,508 d](/filings/0000277948-26-000006.md) | [3,482](/filings/0000277948-26-000014.md) | [3,935](/filings/0000277948-26-000032.md) | [4,017](/filings/0000277948-26-000040.md) |
| Operating income | $m | [1,315](/filings/0000277948-25-000008.md) | [1,337](/filings/0000277948-25-000028.md) | [1,448](/filings/0000277948-25-000044.md) | [1,354](/filings/0000277948-25-000054.md) | [1,106 d](/filings/0000277948-26-000006.md) | [1,041](/filings/0000277948-26-000014.md) | [1,283](/filings/0000277948-26-000032.md) | [1,087](/filings/0000277948-26-000040.md) | [1,110 d](/filings/0000277948-26-000006.md) | [1,253](/filings/0000277948-26-000014.md) | [1,506](/filings/0000277948-26-000032.md) | [1,570](/filings/0000277948-26-000040.md) |
| Interest expense | $m | [204 d](/filings/0000277948-26-000006.md) | [210](/filings/0000277948-25-000028.md) | [209](/filings/0000277948-25-000044.md) | [206](/filings/0000277948-25-000054.md) | [207 d](/filings/0000277948-26-000006.md) | [209](/filings/0000277948-26-000014.md) | [212](/filings/0000277948-26-000032.md) | [210](/filings/0000277948-26-000040.md) | [213 d](/filings/0000277948-26-000006.md) | [213](/filings/0000277948-26-000014.md) | [211](/filings/0000277948-26-000032.md) | [207](/filings/0000277948-26-000040.md) |
| Income tax | $m | [262](/filings/0000277948-25-000008.md) | [288](/filings/0000277948-25-000028.md) | [304](/filings/0000277948-25-000044.md) | [290](/filings/0000277948-25-000054.md) | [203 d](/filings/0000277948-26-000006.md) | [212](/filings/0000277948-26-000014.md) | [264](/filings/0000277948-26-000032.md) | [204](/filings/0000277948-26-000040.md) | [200 d](/filings/0000277948-26-000006.md) | [256](/filings/0000277948-26-000014.md) | [318](/filings/0000277948-26-000032.md) | [332](/filings/0000277948-26-000040.md) |
| Net income | $m | [882](/filings/0000277948-25-000008.md) | [880](/filings/0000277948-25-000054.md) | [963](/filings/0000277948-25-000054.md) | [894](/filings/0000277948-25-000054.md) | [733 d](/filings/0000277948-26-000006.md) | [646](/filings/0000277948-26-000040.md) | [829](/filings/0000277948-26-000040.md) | [694](/filings/0000277948-26-000040.md) | [720 d](/filings/0000277948-26-000006.md) | [807](/filings/0000277948-26-000040.md) | [1,002](/filings/0000277948-26-000040.md) | [1,052](/filings/0000277948-26-000040.md) |
| Diluted EPS | $ per share | [0.45](/filings/0000277948-25-000008.md) | [0.45](/filings/0000277948-25-000028.md) | [0.49](/filings/0000277948-25-000044.md) | [0.46](/filings/0000277948-25-000054.md) | not reported | [0.34](/filings/0000277948-26-000014.md) | [0.44](/filings/0000277948-26-000032.md) | [0.37](/filings/0000277948-26-000040.md) | not reported | [0.43](/filings/0000277948-26-000014.md) | [0.54](/filings/0000277948-26-000032.md) | [0.57](/filings/0000277948-26-000040.md) |
| Basic EPS | $ per share | [0.45](/filings/0000277948-25-000008.md) | [0.45](/filings/0000277948-25-000028.md) | [0.50](/filings/0000277948-25-000044.md) | [0.46](/filings/0000277948-25-000054.md) | not reported | [0.34](/filings/0000277948-26-000014.md) | [0.44](/filings/0000277948-26-000032.md) | [0.37](/filings/0000277948-26-000040.md) | not reported | [0.43](/filings/0000277948-26-000014.md) | [0.54](/filings/0000277948-26-000032.md) | [0.57](/filings/0000277948-26-000040.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $bn | [3.4](/filings/0000277948-25-000008.md) | [3.4](/filings/0000277948-25-000008.md) | [3.2](/filings/0000277948-24-000047.md) | [3.6](/filings/0000277948-24-000054.md) | [2.8](/filings/0000277948-26-000006.md) | [3.0](/filings/0000277948-25-000028.md) | [2.3](/filings/0000277948-25-000044.md) | [2.5](/filings/0000277948-25-000054.md) | [2.6](/filings/0000277948-26-000040.md) | [3.1](/filings/0000277948-26-000014.md) | [3.4](/filings/0000277948-26-000032.md) | [3.6](/filings/0000277948-26-000040.md) |
| Total assets | $bn | [42.2](/filings/0000277948-26-000006.md) | [42.5](/filings/0000277948-25-000008.md) | [42.4](/filings/0000277948-24-000047.md) | [43.1](/filings/0000277948-24-000054.md) | [42.8](/filings/0000277948-26-000006.md) | [43.2](/filings/0000277948-25-000028.md) | [42.9](/filings/0000277948-25-000044.md) | [43.3](/filings/0000277948-25-000054.md) | [43.7](/filings/0000277948-26-000040.md) | [44.2](/filings/0000277948-26-000014.md) | [44.7](/filings/0000277948-26-000032.md) | [45.2](/filings/0000277948-26-000040.md) |
| Current liabilities | $bn | [3.2](/filings/0000277948-25-000008.md) | [3.0](/filings/0000277948-25-000008.md) | [2.7](/filings/0000277948-24-000047.md) | [2.6](/filings/0000277948-24-000054.md) | [3.3](/filings/0000277948-26-000006.md) | [3.4](/filings/0000277948-25-000028.md) | [3.0](/filings/0000277948-25-000044.md) | [3.0](/filings/0000277948-25-000054.md) | [3.1](/filings/0000277948-26-000040.md) | [3.2](/filings/0000277948-26-000014.md) | [4.2](/filings/0000277948-26-000032.md) | [4.3](/filings/0000277948-26-000040.md) |
| Total liabilities | $bn | [30.2](/filings/0000277948-25-000008.md) | [30.0](/filings/0000277948-25-000008.md) | [29.7](/filings/0000277948-24-000047.md) | [30.1](/filings/0000277948-24-000054.md) | [30.3](/filings/0000277948-26-000006.md) | [31.0](/filings/0000277948-25-000028.md) | [30.6](/filings/0000277948-25-000044.md) | [30.5](/filings/0000277948-25-000054.md) | [30.5](/filings/0000277948-26-000040.md) | [30.7](/filings/0000277948-26-000014.md) | [30.6](/filings/0000277948-26-000032.md) | [30.8](/filings/0000277948-26-000040.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [12.0](/filings/0000277948-26-000006.md) | [12.4](/filings/0000277948-25-000054.md) | [12.6](/filings/0000277948-25-000054.md) | [12.9](/filings/0000277948-25-000054.md) | [12.5](/filings/0000277948-26-000040.md) | [12.2](/filings/0000277948-26-000040.md) | [12.4](/filings/0000277948-26-000040.md) | [12.8](/filings/0000277948-26-000040.md) | [13.2](/filings/0000277948-26-000040.md) | [13.6](/filings/0000277948-26-000040.md) | [14.1](/filings/0000277948-26-000040.md) | [14.4](/filings/0000277948-26-000040.md) |

- Cash and equivalents: not reported
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,489 d](/filings/0000277948-26-000006.md) | [1,066](/filings/0000277948-25-000028.md) | [1,107 d](/filings/0000277948-25-000044.md) | [1,686 d](/filings/0000277948-25-000054.md) | [1,388 d](/filings/0000277948-26-000006.md) | [1,255](/filings/0000277948-26-000014.md) | [635 d](/filings/0000277948-26-000032.md) | [1,337 d](/filings/0000277948-26-000040.md) | [1,386 d](/filings/0000277948-26-000006.md) | [1,272](/filings/0000277948-26-000014.md) | [1,327 d](/filings/0000277948-26-000032.md) | [1,617 d](/filings/0000277948-26-000040.md) |
| Capital expenditure | $m | [686 d](/filings/0000277948-26-000006.md) | [517](/filings/0000277948-25-000028.md) | [549 d](/filings/0000277948-25-000044.md) | [625 d](/filings/0000277948-25-000054.md) | [838 d](/filings/0000277948-26-000006.md) | [719](/filings/0000277948-26-000014.md) | [776 d](/filings/0000277948-26-000032.md) | [730 d](/filings/0000277948-26-000040.md) | [677 d](/filings/0000277948-26-000006.md) | [543](/filings/0000277948-26-000014.md) | [576 d](/filings/0000277948-26-000032.md) | [593 d](/filings/0000277948-26-000040.md) |
| Dividends paid | $m | [216 d](/filings/0000277948-26-000006.md) | [235](/filings/0000277948-25-000028.md) | [233 d](/filings/0000277948-25-000044.md) | [232 d](/filings/0000277948-25-000054.md) | [230 d](/filings/0000277948-26-000006.md) | [245](/filings/0000277948-26-000014.md) | [243 d](/filings/0000277948-26-000032.md) | [242 d](/filings/0000277948-26-000040.md) | [242 d](/filings/0000277948-26-000006.md) | [260](/filings/0000277948-26-000014.md) | [260 d](/filings/0000277948-26-000032.md) | [259 d](/filings/0000277948-26-000040.md) |
| Share repurchases | $m | [581 d](/filings/0000277948-26-000006.md) | [247](/filings/0000277948-25-000028.md) | [563](/filings/0000277948-24-000047.md) | [402](/filings/0000277948-24-000054.md) | [1,025 d](/filings/0000277948-26-000006.md) | [751](/filings/0000277948-26-000014.md) | [421 d](/filings/0000277948-26-000032.md) | [112 d](/filings/0000277948-26-000040.md) | [112 d](/filings/0000277948-26-000006.md) | [222](/filings/0000277948-26-000014.md) | [296 d](/filings/0000277948-26-000032.md) | [543 d](/filings/0000277948-26-000040.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [2,058](/filings/0000277948-24-000032.md) | [2,025](/filings/0000277948-24-000047.md) | [1,999](/filings/0000277948-24-000054.md) | [1,962](/filings/0000277948-25-000028.md) | [1,948](/filings/0000277948-25-000044.md) | [1,940](/filings/0000277948-25-000054.md) | [1,892](/filings/0000277948-26-000014.md) | [1,869](/filings/0000277948-26-000032.md) | [1,867](/filings/0000277948-26-000040.md) | [1,862](/filings/0000277948-26-000014.md) | [1,859](/filings/0000277948-26-000032.md) | [1,853](/filings/0000277948-26-000040.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,843,398,210 at 2026-09-30, from the cover of the [10-Q filed 2026-10-21](/filings/0000277948-26-000040.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.